Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using electrical stimulation to relieve chronic pain in patients with inflammatory demyelinating diseases

Official title: A Study on the Therapeutic Effects of Transcranial Electrical Stimulation Combined on Chronic Pain in Central Nervous System Inflammatory Demyelinating Diseases

Run by Xuanwu Hospital, Beijing · NCT06942611 · Data updated 2026-11-12

This study is testing whether a type of electrical stimulation can help relieve chronic pain in people with inflammatory demyelinating diseases.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment80 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedMay 3, 2025
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedJuly 1, 2025
Trial IDNCT06942611 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 to 65 diagnosed with neuromyelitis optica spectrum disorder, multiple sclerosis, or other related conditions, who have a pain score of 4 or higher.

Probably not a fit

Patients with recent relapses, significant medication adjustments, or those with implanted devices like pacemakers may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of transcranial electrical stimulation combined with a visual placebo on alleviating symptoms such as painful spasms in patients with idiopathic inflammatory demyelinating disorders of the central nervous system. It aims to assess the therapeutic efficacy of this non-invasive neurostimulation approach while considering individual differences in neural responsiveness. The study will also explore the relationship between imaging characteristics, electrophysiological features, and clinical manifestations of the disease. By analyzing these factors, the research seeks to identify key determinants of treatment efficacy.

Why it matters

Potential benefit: If successful, this approach could significantly improve pain management for patients suffering from chronic pain associated with inflammatory demyelinating diseases.

How similar studies have gone: While non-invasive neurostimulation has shown promise in similar contexts, this specific combination of techniques is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients diagnosed with neuromyelitis optica spectrum disorder, multiple sclerosis, or other central nervous system inflammatory demyelinating diseases that meet the diagnostic criteria;

Numeric Rating Scale (NRS) pain score ≥4;

Age between 18 and 65 years, regardless of gender;

Stable dose of immunosuppressive therapy for at least one month;

EDSS score ≤6;

Right-handed;

Agree to participate and sign the informed consent form.

Exclusion Criteria:

A history of relapse within the past month;

Recent medication adjustments or treatment with modified electroconvulsive therapy, transcranial magnetic stimulation, or other neurostimulation techniques within the past month;

Participation in any other clinical trial within the past month or currently participating in another clinical trial;

Presence of cochlear implants, pacemakers, or implanted stimulators in the brain;

Skin integrity at the electrode placement site is compromised, or allergy to electrode gel or adhesive;

A history of epilepsy, hydrocephalus, central nervous system tumors, brain injury, or intracranial infections;

Pregnant or breastfeeding women, or those planning to become pregnant in the near future;

A score of ≥3 on item 3 (suicide item) of the HDRS-17, or a history of severe psychiatric disorders;

Presence of severe or unstable organic diseases;

Poor patient compliance preventing cooperation with treatment, follow-up, or clinical, EEG, and imaging data collection;

Any other situation deemed unsuitable for participation in the study by the investigator.

Where it's running

  • Xuanwu Hospital, Capital Medical University
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.